Home › Therapeutic areas › Autonomic agents
Japan market screening · Therapeutic class
自律神経剤 · Japan Standard Commodity Classification
9 molecules in this class are marketed in Japan across 18 products. 7 of those products are not shipping normally today — 38.9% of the class. Supply status is reported to the Ministry of Health, Labour and Welfare and updated daily.
Ordered by how many products compete. Constrained means limited supply or supply suspended; supply suspended does not mean discontinued.
| Molecule | Products | Companies | Constrained | Supply mix |
|---|---|---|---|---|
| Tiquizium Bromideチキジウム臭化物 | 9 | 4 | 3 | |
| Neostigmine Methylsulfateネオスチグミンメチル硫酸塩 | 2 | 1 | 2 | |
| Ambenonium Chlorideアンベノニウム塩化物 | 1 | 1 | — | |
| Bethanechol Chlorideベタネコール塩化物 | 1 | 1 | — | |
| Mepenzolate Bromideメペンゾラート臭化物 | 1 | 1 | — | |
| Neostigmine Bromideネオスチグミン臭化物 | 1 | 1 | — | |
| Neostigmine Methylsulfate / Atropine Sulfate Hydrateネオスチグミンメチル硫酸塩・アトロピン硫酸塩水和物 | 1 | 1 | — | |
| Propantheline Bromideプロパンテリン臭化物 | 1 | 1 | 1 | |
| Pyridostigmine Bromideピリドスチグミン臭化物 | 1 | 1 | 1 |
Products counts every marketed product across all strengths and forms, not companies. Companies is the number of companies marketing that molecule; the same company may appear under several molecules, so the column does not add up to a class total. Market size sits on each molecule's own page, valued at national price rather than transaction price. Figures are as at 2026-08-28.
Tell us which molecules matter to you. We will tell you what the public data can and cannot answer before you commission anything.
Send an enquiryOur Database Division replies in English within three business days (Japan time).